NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
POINT Biopharma Global, Inc. (NASDAQ:PNT)'s sale to Eli Lilly for $12.50 per share in cash. If you are a POINT Biopharma shareholder, click here to learn more about your rights and options.
Renovaro Biosciences Inc. (NASDAQ:RENB)'s merger with GEDi Cube Intl Ltd. Under the terms of the proposed transaction, all of GEDi Cube's outstanding equity interests will be exchanged for shares of ...